Want to join the conversation?
$DOV 2Q15 Q&A: Sprague of Vertical Research asked about 2H15 forecast on Energy. Bob said that second half versus first half the revenue was down $40MM, but the second half run rate is fairly consistent with the second quarter. The company plans to exit the year with a 20% margin in Energy. 4Q15 exit rate is expected to be 15% or 15.5% margins.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.